AstraZeneca, Bespak in Supply Pact for Inhalers
AstraZeneca has formed a multi-year commercial supply agreement with Norfolk, UK-based Bespak, a Consort Medical company, for the scale-up and supply of Bespak’s proprietary pressurized metered dose inhaler valves and actuators. Consort Medical is the parent company of Bespak, a manufacturer of drug-delivery devices, and Aesica, a contract development and manufacturing organization
These components will be assembled with AstraZeneca’s Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol indicated for the long-term, maintenance treatment of chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema. AstraZeneca’s device was approved by the US Food and Drug Administration in April 2016.
These products will be manufactured in Bespak’s existing King’s Lynn facility in Norfolk.